Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Multivitamins: Are they a scam?
Are chiropractors charlatans or misunderstood?
Does anti-ageing skincare actually work?
What's the deal with night terrors?
Why do we eat cereal for breakfast?
Working out? Why 'No Pain No Gain' is bull
Is there such thing as TOO much sun protection?
Can you adapt to allergies or does the dog have to go?
Why do you feel so tired after a big meal?
Can listening to music make you smarter?
Am I addicted to caffeine?
What is the perfect nap duration?
Are probiotics worth the money?
Does it matter whether I enjoy exercise?
End of Coronacast, but we're not going away!
INTRODUCING — Hello AI Overlords (and some Coronacast news!)
Getting a (strong) grip on Long COVID
When will we be out of the COVID pandemic phase?
We're finally feeling a bit less lonely!
Why the risk of Long COVID might be falling
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First